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Abstract
Assessment of cardiovascular disease (CVD) morbidity and mortality in subnational areas is 
limited. A model for regional CVD surveillance is needed, particularly among vulnerable 
populations underrepresented in current monitoring systems. The Mississippi Delta 
Cardiovascular Health Examination Survey (CHES) is a population-based, cross-sectional study 
on a representative sample of adults living in the 18-county Mississippi Delta region, a rural, 
impoverished area with high rates of poor health outcomes and marked health disparities. The 
primary objectives of Delta CHES are to (1) determine the prevalence and distribution of CVD 
and CVD risk factors using self-reported and directly measured health metrics and (2) to assess 
environmental perceptions and existing policies that support or deter healthy choices. An address-
based sampling frame is used for household enumeration and participant recruitment and an in-
home data collection model is used to collect survey data, anthropometric measures, and blood 
samples from participants. Data from all sources will be merged into one analytic dataset and 
sample weights developed to ensure data are representative of the Mississippi Delta region adult 
population. Information gathered will be used to assess the burden of CVD and guide the 
development, implementation, and evaluation of cardiovascular health promotion and risk factor 
control strategies.
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1. Introduction
Cardiovascular disease (CVD) is the leading cause of mortality in the United States [1], 
accounting for over 25% of all deaths [1]. CVD data collected by surveillance systems allow 
for the appropriate allocation of limited resources and focused programmatic planning and 
intervention. National surveillance systems track CVD and its related risk factors using a 
collection of representative surveys (e.g., National Health and Nutrition Examination Survey 
(NHANES)). However, equivalent regional or local level surveillance of CVD is not 
currently available, and coordination of CVD surveillance is lacking [2]. Development of a 
replicable, scalable, and flexible model for local level surveillance is needed, particularly 
among vulnerable populations potentially underrepresented in current systems.
The 18-county Mississippi Delta region consistently ranks among the most disadvantaged 
areas in the nation, with approximately one-quarter of its population living below the federal 
poverty level (Table 1) [3]. Residents of the Mississippi Delta region experience age-
adjusted rates of death due to major CVDs that are considerably higher than Mississippi and 
national rates and marked racial health disparities exist (Table 2).
States and localities benefit from reliable, timely, and accurate health information. The 
Behavioral Risk Factor Surveillance System (BRFSS) is frequently used to track a broad 
range of health indicators and direct programmatic planning at the state level. The 
methodology of the BRFSS allows for a large annual sample size and comparisons across 
states and large metropolitan areas. However, the BRFSS has limitations, including the use 
of random-digit-dialing to select participants and reliance on self-reported data. Moreover, 
telephone-based surveillance systems have noncoverage biases and comparisons between 
self-reported and measured health metrics have found inconsistencies, with significant over- 
and underestimation of CVD risk factors among population subgroups [5–9].
To further develop a model for CVD surveillance at the regional level and to examine the 
CVD risk factors in an area with significant health needs, the Mississippi State Department 
of Health (MSDH), with support from the Centers for Disease Control and Prevention 
(CDC), developed and initiated a Cardiovascular Health Examination Survey (CHES) in the 
Mississippi Delta region. The Delta CHES will provide a baseline examination of CVD and 
related risk factors, which can be later replicated to assess progression and/or progress 
among adult residents of the Mississippi Delta region. The primary objectives of Delta 
CHES are (1) to determine the prevalence and distribution of CVD and CVD risk factors 
using self-reported and directly measured health metrics and (2) to assess environmental 
perceptions and existing policies that support or deter healthy choices. The secondary 
objectives are (1) to develop a replicable, regional-level data collection model for use in 
future studies and (2) to create a blood repository for use in future ancillary studies. 
Information gathered will help guide the state in the development, implementation, and 
evaluation of cardiovascular health promotion and risk factor control strategies. Here we 
describe the Delta CHES design and methods.
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2. Materials and Methods
2.1. Development of the Model
The methods and model used in the Delta CHES were informed using comparable pilot 
surveys conducted in four US states (Washington [9], Arkansas [10], Kansas, and 
Oklahoma). Previous pilot surveys were undertaken to address a gap in available data at the 
local, regional, and state levels. The Delta CHES model was developed to provide regional 
estimates by using a detailed process and outcome evaluation conducted among the four 
pilot states and incorporating historical accounts of other local and regional data collection 
surveys (e.g., Survey of the Health of Wisconsin [11]; New York City Health and Nutrition 
Examination Survey [12]).
Lessons learned from previous pilot surveys influenced the ordering of tasks during 
planning stages, the selection of a sampling method, and the choice for the Delta CHES 
model. Potential causes of delay identified by pilot surveys, such as institutional review 
board (IRB) approval, staffing, questionnaire development, and selection and use of 
contractors for data collection and management were prioritized during the initial phases of 
Delta CHES. Methods employed by prior examination surveys varied from in-home data 
collection for all aspects of the survey to telephone-based data collection of self-reported 
data and measured health data conducted at clinic sites. Variations in response rates and 
health outcome findings from prior surveys led to the selection of in-home data collection of 
self-reported and measured data for Delta CHES.
2.2. Study Design
Delta CHES is a population-based, cross-sectional study. Survey data, anthropometric 
measures, and blood samples are collected from individuals ≥18 years from the adult, 
noninstitutionalized population of the Mississippi Delta region. The MSDH IRB approved 
all Delta CHES procedures and documents. The planning phase began in 2011, and the 
implementation phase began in late 2012 with expectations of completion in early 2014.
2.3. Study Population
The Mississippi Delta region, an area the size of Connecticut in the Northwest part of 
Mississippi with a population of approximately 553,000, includes the following 18 counties: 
Bolivar, Carroll, Coahoma, Desoto, Holmes, Humphreys, Issaquena, Leflore, Panola, Quit-
man, Sharkey, Sunflower, Tallahatchie, Tate, Tunica, Warren, Washington, and Yazoo 
(Figure 1). Individuals are eligible to participate in Delta CHES if they are ≥18 years of age, 
nonpregnant, reside within the 18-county Mississippi Delta region, and are able to sign an 
informed consent form. Persons who cannot legally sign a consent form, persons with 
psychiatric, cognitive, or developmental disorders, persons with hemophilia, those 
undergoing treatment for cancer, non-English speakers, and those who are not expected to 
be in residence within 30 days of selection are excluded.
2.4. Sample Size and Power
One of our main interests is to compare prevalence estimates between non-Hispanic blacks 
and non-Hispanic whites, within the limits of sample size feasibility. Table 3 shows the 
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sample sizes needed to have a power of 80% to detect a difference in leading CVD risk 
factor (i.e., dyslipidemia, hypertension, and, diabetes) prevalence between these two groups 
(Table 3). Based on a similar study conducted in Arkansas [10], we expect about one-third 
of contacted houses to have an eligible adult willing to participate and a 65% completion 
rate among surveys started. With 80% probability of detecting a true difference, at the 0.05 
significance level, between equal-sized samples of non-Hispanic blacks and non-Hispanic 
whites, we estimate a total sample size of approximately 1,000 which will allow us to detect 
differences in selected CVD risk factors.
2.5. Sampling and Recruitment
The Mississippi Delta region can be a difficult place to conduct health surveys due to many 
factors, including the rurality of the area, low landline telephone coverage, and low 
socioeconomic status of many residents. Therefore, innovative means are used to sample 
and recruit participants into Delta CHES. First, a two-stage address-based sampling method 
is used to sample households and participants. This approach reduces the potential coverage 
bias of traditional random-digit dialing. In the latter half of 2012, approximately 38% of US 
homes had only cellular phones [13]. In a recent comparison with other states, Mississippi 
had one of the highest proportions of adults in wireless-only households (42.3%) [14]. 
Further, adults living in cellular phone-only households tend to be younger, have lower 
incomes, and be members of minority populations [14], increasing the risk for coverage bias 
in Mississippi Delta communities with high percentages of non-Hispanic blacks and lower 
income households.
The frame for the first stage of sampling, which consisted of residential addresses in the 
Delta region, was purchased from a private vendor (Marketing Systems Group; http://
www.m-s-g.com). The basis of this file is the US Postal Service Computerized Delivery 
Sequence File, which contains nearly all delivery-point addresses served by the US Postal 
Service [15]. Geographic information systems technology was used to construct an address 
frame that matched the geographies of the Delta CHES population and addresses were 
matched to telephone numbers (~47% matching rate). Approximately 6,000 households 
were randomly selected from the list of addresses.
The second stage of sampling involves the selection of eligible adults for participation in 
Delta CHES. Each randomly selected household is mailed a letter which describes the study, 
identifies the household as being part of the survey sample, and informs residents that field 
staff would be calling the household. The letter also requests the household to contact study 
staff via a toll-free number to confirm the telephone number on file or to provide a telephone 
number so that they can be contacted regarding participation. This letter is particularly 
useful for those households where telephone matching is unsuccessful. Any returned or 
undeliverable letters are receipted into an electronic management system and the outcome of 
the mailing logged with an appropriate disposition code.
For addresses with an associated telephone number, trained telephone interviewers call the 
households to complete an enumeration survey. Interviewers make up to seven attempts to 
contact an adult household member at different times of the day and different days of the 
week including weekends. If contact is made, interviewers verify that they have reached the 
Short et al. Page 4
Epidemiol Res Int. Author manuscript; available in PMC 2015 April 02.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
correct household, introduce and briefly explain Delta CHES, and administer the 
enumeration survey using a computer-assisted telephone interviewing (CATI) system. The 
name, age, sex, and phone number of each eligible household member is collected. Each 
contact attempt is tracked and households where telephone contact attempts are unsuccessful 
are reassigned for in-person enumeration.
An in-person household enumeration is used for any household for which there is not a valid 
telephone number or when telephone contact attempts are unsuccessful. Due to the high 
travel costs associated with in-person enumeration, only one visit is made to each home. The 
enumeration survey is programmed on handheld devices and allows for direct entry of 
information (i.e., name, age, sex, and phone number of each eligible household member) by 
interviewers. A door hanger is left at those houses where field staff are unable to reach a 
person during the visit. The door hanger describes Delta CHES and requests the household 
to call study staff via a toll-free telephone number to discuss participation in Delta CHES.
Once households are enumerated, one to two (depending on household size) eligible adults 
from each household are selected. Sampled residents are called to obtain verbal agreement 
to participate in Delta CHES. Up to seven attempts are made to reach each selected potential 
participant at different times of the day and different days of the week and a CATI 
recruitment script and data collection instrument is used to electronically capture all 
responses. If the randomly selected adult agrees to participate in Delta CHES, field-
screening staff verify contact information and send this information to the data collection 
staff. At this time, each participant is assigned a unique identification number which is used 
throughout the study for tracking purposes.
To compensate for recruitment challenges of the random sampling strategy, recruitment of 
participants also includes a “self-selected” sample. Similar strategies have been used by 
other major CVD epidemiological studies, including the Framingham Heart Study [16] and 
the Jackson Heart Study [17]. Enrollment into Delta CHES is open to volunteers who meet 
census-derived age, sex, and race eligibility criteria for the 18-county region. An enrollment 
algorithm based on US Census data for each county determines anticipated recruitment for 
each age*sex*race subgroup. Individuals interested in participating in Delta CHES are asked 
to call the study’s toll-free number to complete the screener questionnaire. The name and 
contact information of each recruited participant is subsequently sent to the data collection 
staff. The volunteer sample is targeted to not exceed the sample size of those randomly 
selected and at the end of the study, randomly and self-selected participants will be 
compared to assess differences in key characteristics.
2.6. Data Collection
Examination Management Services, Inc. (EMSI), a provider of specimen collection services 
for clinical trials and epidemiological studies, is responsible for scheduling and completing 
an interview and examination appointment at each participant’s home. All field workers are 
required to complete training on the Delta CHES data collection protocol and adherence to 
National Institutes of Health data collection standards and protection of human subjects and 
obtain EMSI Human Participation and Protection certification prior to making any study 
visits. EMSI calls each participant 48 hours prior to the study visit to request a 9-hour fast. 
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At the study home visit, written consent is obtained and questionnaire data, anthropometric 
measurements and blood samples are collected. The main Delta CHES questionnaire 
domains, physical measures, and blood tests are found in Table 4. A label containing the 
participant’s unique identification number is placed on all study-related materials at each 
data collection visit.
2.6.1. Questionnaire—The Delta CHES questionnaire consists of up to 281 questions 
(depending on skip patterns) and is interviewer-administered with responses recorded 
directly on the paper form. The questionnaire includes questions related to medical history, 
CVD risk factors and behaviors (e.g., smoking, alcohol use, physical activity, and diet), and 
sociodemographics. Physical and built environments and community perceptions and 
existing health-related policies that support or deter healthy choices are also assessed. 
Participants are asked to present prescription and nonprescription medicines, including 
vitamins, supplements, and over-the-counter medications. The draft questionnaire was field-
tested at a MSDH office in the Mississippi Delta region with community volunteers. 
Reactions, difficulties, and questions by respondents were noted systematically and 
discussed by Delta CHES staff and the questionnaire was revised accordingly. Many of the 
survey questions originated from established national (i.e., NHANES) or state-based surveys 
(e.g., BRFSS). The complete Delta CHES questionnaire is available on the study’s website 
[18].
2.6.2. Physical Examination—The physical examination includes anthropometric and 
blood pressure measurements. Participants are measured for height, weight, and hip and 
waist circumference. Weight is measured on hard surface floor (if available) using a digital 
scale (Healthometer) and recorded in pounds to the nearest decimal. Height is measured on 
hard surface floor (if available) using a metal tape measure with the participant’s heels and 
buttocks against a wall and recorded in feet and inches to the nearest half inch. Waist 
circumference is measured with a soft measuring tape at umbilicus level, keeping the tape 
parallel to the floor. The measurement is recorded in inches to the nearest half inch. Hip 
circumference is measured at the widest point of the participant’s buttocks with the soft 
measuring tape parallel to the floor. It is recorded in inches to the nearest half inch. Resting 
blood pressure is measured in the right arm, if available, three times in the seated position 
with an American Diagnostic Corporation (Hauppauge, New York) sphygmomanometer. 
There is a five-minute waiting period before taking the first blood pressure and a 30-second 
period between measurements. Equipment is calibrated daily using standardized protocols 
and compared to the previous day’s measurement.
2.6.3. Biological Specimen Collection—After administering the questionnaire and 
taking anthropometric measurements, interviewers collect approximately 36mL of blood 
from each participant in a requested fasting state. All specimens are processed and shipped 
overnight to laboratories for analysis according to protocol (Table 5). The Mississippi Public 
Health Laboratory (Jackson, MS), a laboratory currently participating in the CDC Lipid 
Standardization Program [19], is responsible for the lipid assay. All remaining samples are 
analyzed by Laboratory Corporation of America (LabCorp) [20].
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A portion of the blood collected during examination is stored for potential use in future 
health studies. Participants who provide consent for storage of blood have 5mL of their 
serum stored at −70°C in a secure laboratory space at the Mississippi Public Health 
Laboratory. Future studies may be conducted using stored samples which will be identified 
using the participant’s unique identification number. Researchers from public health 
agencies, universities, and other scientific centers can submit proposals to use the stored 
specimens, as well as other Delta CHES data. All research proposals will be reviewed for 
scientific merit and integrity by the MSDH IRB.
2.6.4. Food Frequency Questionnaire—At the end of the study visit, each participant 
is provided a food frequency questionnaire (FFQ), one-page instructions for completing the 
FFQ, a pencil, and a postage-paid preaddressed return envelope. The Delta CHES toll-free 
800 number is included in the instructions and participants can call study staff with 
questions concerning the FFQ or to obtain assistance with completing it. The FFQ was 
developed by the Nutrition Assessment Shared Resource of Fred Hutchinson Cancer 
Research Center (Seattle, WA). This FFQ was chosen because it has an advantage of being 
comparable to the other CHES exam sites (i.e., Arkansas) and can provide an overall 
assessment of sodium intake, an important CVD risk factor. The self-administered FFQ 
booklet asks participants to report the frequency of consumption and portion size of 
approximately 120 line items over the past three months. Each line item is defined by a 
series of foods or beverages. Participants complete the FFQ and return it to MSDH. 
Approximately two weeks after the initial study visit, a call is made to nonresponding 
participants to remind them to complete the FFQ. Two weeks after the reminder call, a 
second call is made to nonresponding participants.
2.6.5. Pedometer and Daily Steps Diary—Following completion of the main Delta 
CHES data collection, participants are also given a pedometer kit to self-monitor physical 
activity for five consecutive days. Pedometers are a simple, inexpensive way to measure 
physical activity [21] and five consecutive days of data collection are enough to achieve a 
reliable and valid estimate of physical activity [22]. Kits include a pedometer, instructions 
on how to use the pedometer, a recording diary, and a postage-paid preaddressed return 
envelope. Interviewers provide assistance in opening and resetting the pedometers, if 
necessary. Study pedometers are the Yamax SW200 models, which demonstrate high 
concordance with accelerometers under laboratory conditions and in field settings [23]. The 
Yamax SW200 has been recommended in a number of validation studies as a preferred 
model for measuring daily steps in free-living populations [24, 25]. Participants are 
instructed to reset their pedometer to zero each morning, go about their typical activities, 
remove the pedometer only while bathing, showering, or swimming, and record their day-
end steps taken on the provided diary. The completed diary is returned to MSDH; 
participants keep the pedometers. Approximately two weeks after the initial study visit, a 
call is made to nonresponding participants to remind them to complete the pedometer diary. 
Two weeks after the reminder call, a second call is made to nonresponding participants.
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2.7. Data Integrity and Quality
Several steps are taken to ensure data integrity and quality. First, a 50% random subsample 
of respondents is telephoned after the study visit to assess the overall experience with the 
interviewers. Issues are reported to EMSI for resolution. Second, all data collection tools are 
hand-checked for readability, correct skip patterns and missing data as they are received by 
MSDH. Delta CHES staff call participants to verify information when needed. Lastly, 
laboratory analyses are conducted using industry recognized standards and are subjected to 
internal laboratory quality monitoring by the Mississippi Public Health Laboratory and 
LabCorp.
2.8. Data Management
MSDH acts as the data coordinating center for Delta CHES. At the end of the in-home data 
collection period, MSDH will collate all questionnaires. Data will be entered, processed, and 
weighed and results will be compiled into one dataset. MSDH logs and ships the FFQs, 
mailed back by participants, to the Fred Hutchinson Cancer Research Center for scanning 
and processing. The pedometer diary data are entered into a Delta CHES database as 
received, and laboratory results are transmitted electronically to MSDH. After data from all 
sources are received and entered, data will be merged into one master database, matched by 
the participant’s unique identification number. The final analytic dataset will be in aggregate 
and void of personal identifiers. All subsequent data analyses will use this dataset to protect 
the confidentiality of participants.
2.9. Notification of Study Findings
A cover letter and a health report summarizing anthropometric measurements and clinically 
relevant laboratory results are mailed to each participant. Participants are encouraged to 
share results with their health care provider. A local telephone number is provided in the 
letter for medical provider referral information for individuals without a health care 
provider. Participants are called and advised to seek medical care when any laboratory 
results or blood pressure readings are above predetermined critical values. Participant 
feedback is based on the urgency for medical attention, using guidelines from the Seventh 
Report of the Joint National Committee on Prevention, Detection, Evaluation, and 
Treatment of High Blood Pressure [26].
2.10. Incentives
In addition to the health report and pedometer, a $45 gift card is given to each participant as 
compensation for completing the study visit. Participants receive a $10 gift card for 
returning the FFQ and a $10 gift card for returning the pedometer diary. The incentives are 
mailed to the participant’s home together with the cover letter, the health report, and CVD-
related educational materials. If the FFQ and/or pedometer daily steps diary are received 
after the letter and report are mailed, then incentives are mailed immediately following 
receipt of the FFQ and/or pedometer daily steps diary.
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2.11. Epidemiological Implications
While data from the national surveillance systems are used to provide reliable, directly 
measured health data for the nation, comparable state or regional-level data are not available 
to track leading health indicators and inform local-level policies and interventions. Since 
data collected by surveillance and monitoring systems allow for the appropriate allocation of 
limited resources and focused programmatic planning and intervention, localized systems 
are important.
Delta CHES is an integrated model designed to assess the burden of CVD and examine 
policy and environmental factors that influence CVD and its risk factors in the 18-county 
Mississippi Delta region. Delta CHES will fill a gap in applied population health by adding 
detailed information on chronic disease health outcomes and determinants at the regional 
level. Some of this information, such as levels of undiagnosed or uncontrolled disease and 
risk factors, is available for the first time at this level. Data can be used to develop localized 
CVD control strategies and to support policy and environmental interventions in the 
Mississippi Delta region that promote health. As the deleterious effects of CVD risk factors 
occur prior to a diagnosis or adverse health event, the identification and assessment of those 
unaware of major CVD risk factors, findings unavailable using a telephone-based survey, is 
a valuable example of one of the benefits of this data collection model. Finally, Delta CHES 
could serve as a demonstration project on how to successfully recruit, enroll, and collect 
data, including measured variables, from rural and other difficult to reach populations, and 
as a model for a future statewide CHES.
Acknowledgments
This work was supported by the Centers for Disease Control and Prevention (Grant Award no. 1U50DP00308). The 
authors especially thank the Delta CHES participants as well as Etonne Bradford, Jane Campbell, Dr. Mary Currier, 
Cassandra Dove, Dr. Alfio Rausa, Dr. Victor Sutton, Dr. Evelyn Walker, Dr. Daphne Ware, and Dr. Lei Zhang 
(Mississippi State Department of Health) and Dr. Sharon Wyatt (University of Mississippi Medical Center). They 
thank the staff at the following institutions for their help in various aspects of the survey: EMSI, Fred Hutchinson 
Cancer Research Center, LabCorp, Mississippi State Department of Health, and Westat.
References
1. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: final data for 2006. 
National Vital Statistics Reports. 2009; 57(14):1–134. [PubMed: 19788058] 
2. Institute of Medicine. A Nationwide Framework For Surveillance of Cardiovascular and Chronic 
Lund Diseases. Washington, DC, USA: The National Academies Press; 2011. 
3. United States Census Bureau: State and County QuickFacts. http://quickfacts.census.gov
4. Ingram DD, Franco SJ. National Center for Health Statistics urban-rural classification scheme for 
counties. Vital and Health Statistics. 2012; 2:1–65. [PubMed: 22783637] 
5. Schenker N, Raghunathan TE, Bondarenko I. Improving on analyses of self-reported data in a large-
scale health survey by using information from an examination-based survey. Statistics in Medicine. 
2010; 29(5):533–545. [PubMed: 20029804] 
6. Gwynn RC, Garg RK, Kerker BD, Frieden TR, Thorpe LE. Contributions of a local health 
examination survey to the surveillance of chronic and infectious diseases in New York City. 
American Journal of Public Health. 2009; 99(1):152–159. [PubMed: 18556616] 
7. Stommel M, Schoenborn CA. Accuracy and usefulness of BMI measures based on self-reported 
weight and height: findings from the NHANES & NHIS 2001–2006. BMC Public Health. 2009; 9 
article 421. 
Short et al. Page 9
Epidemiol Res Int. Author manuscript; available in PMC 2015 April 02.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
8. Taylor A, Grande ED, Gill T, et al. Comparing self-reported and measured high blood pressure and 
high cholesterol status using data from a large representative cohort study. Australian and New 
Zealand Journal of Public Health. 2010; 34(4):394–400. [PubMed: 20649780] 
9. Van Eenwyk J, Bensley L, Ossiander EM, Krueger K. Comparison of examination-based and self-
reported risk factors for cardiovascular disease, Washington state, 2006–2007. Preventing Chronic 
Disease. 2012; 9 Article ID 110321. 
10. Zohoori N, Pulley L, Jones C, Senner J, Shoob H, Merritt RK. Conducting a statewide health 
examination survey: the Arkansas Cardiovascular Health Examination Survey (ARCHES). 
Preventing Chronic Disease. 2011; 8(3):A67. [PubMed: 21477507] 
11. Survey of the Health of Wisconsin. http://www.med.wisc.edu/show/survey-of-the-health-of-
wisconsin/35828
12. New York City Health and Nutrition Examination Survey. http://www.nyc.gov/html/doh/html/
data/nyc-hanes.shtml
13. Blumberg, SJ.; Luke, JV. Wireless substitution: early release of estimates from the National Health 
Interview Survey. 2012. http://www.cdc.gov/nchs/nhis.htm
14. Blumberg SJ, Luke JV, Ganesh N, Davern ME, Boudreaux MH, Soderberg K. Wireless 
substitution: state-level estimates from the National Health Interview Survey, January 2007-June 
2010. National Health Statistics Reports. 2011; 39:1–26. [PubMed: 21568134] 
15. United States Postal Service. Computerized delivery sequence file. http://www.usps.com/business/
address-management-products.htm?
16. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the 
Framingham Study. American Journal of Public Health. 1951; 41(3):279–281. [PubMed: 
14819398] 
17. Fuqua SR, Wyatt SB, Andrew ME, et al. Recruiting African-American research participation in the 
Jackson Heart Study: methods, response rates, and sample description. Ethnicity and Disease. 
2005; 15(4):S6–S6. [PubMed: 16317982] 
18. The Mississippi Delta Cardiovascular Health Examination Survey. http://www.healthyms.com/
deltaches
19. Centers for Disease Control and Prevention Lipid Standardization Program. http://www.cdc.gov/
labstandards/lsp.html
20. Laboratory Corporation of America. http://www.labcorp.com
21. Tudor-Locke C, Bassett DR Jr. How many steps/day are enough? preliminary pedometer indices 
for public health. Sports Medicine. 2004; 34(1):1–8. [PubMed: 14715035] 
22. Tudor-Locke C, Williams JE, Reis JP, Pluto D. Utility of pedometers for assessing physical 
activity: convergent validity. Sports Medicine. 2002; 32(12):795–808. [PubMed: 12238942] 
23. Schneider PL, Crouter SE, Bassett DR Jr. Pedometer measures of free-living physical activity: 
comparison of 13 models. Medicine and Science in Sports and Exercise. 2004; 36(2):331–335. 
[PubMed: 14767259] 
24. Le Masurier GC, Tudor-locke C. Comparison of pedometer and accelerometer accuracy under 
controlled conditions. Medicine and Science in Sports and Exercise. 2003; 35(5):867–871. 
[PubMed: 12750599] 
25. Tudor-Locke C, Ainsworth BE, Tompson RW, Matthews CE. Comparison of pedometer and 
accelerometer measures of free-living physical activity. Medicine and Science in Sports and 
Exercise. 2002; 34(12):2045–2051. [PubMed: 12471314] 
26. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on 
prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. The 
Journal of the American Medical Association. 2003; 289(19):2560–2572.
Short et al. Page 10
Epidemiol Res Int. Author manuscript; available in PMC 2015 April 02.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. 
The 18-county Mississippi Delta region. The Mississippi Delta region (shaded in black) 
includes the following counties: Bolivar, Carroll, Coahoma, Desoto, Holmes, Humphreys, 
Issaquena, Leflore, Panola, Quitman, Sharkey, Sunflower, Tallahatchie, Tate, Tunica, 
Warren, Washington, and Yazoo.
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Table 3
Power to detect statistically significant differences in rates of diabetes, dyslipidemia, and hypertension 
between non-Hispanic black and non-Hispanic white residents of the Mississippi Delta region.
Condition Non-Hispanic blacks
Prevalence (%)a
Non-Hispanic whites
Prevalence (%)a
Power (1 – β) for
alpha = 0.05
Total sample
size
Diabetes 16.0 10.2 0.80 1,006
Dyslipidemia 35.9 45.2 0.80 874
Hypertension 42.5 34.7 0.80 1,234
a
From the 2007 and 2009 combined Mississippi Behavioral Risk Factor Surveillance System.
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Table 4
Mississippi Delta Cardiovascular Health Examination Survey questionnaire domains, physical examination 
measures, and blood tests.
Category
Questionnaire domains
Alcohol consumption; anxiety and depression; aspirin use; cholesterol; diabetes; diet and
nutrition; general health and access to care; health insurance; hypertension; knowledge of signs
and symptoms of heart attack and stroke; medical conditions and family medical history;
community perception and environment; occupation; oral health; perceived stress; physical
activity and physical fitness; reactions to race; social and emotional support; sociodemographic
information and housing; tobacco use and exposure; vitamins and medications; weight history
Physical examination measures Hip and waist circumference; blood pressure; height; pulse; weight
Blood tests
Complete blood count; comprehensive metabolic panel (alanine aminotransferase;
albumin : globulin ratio; albumin, serum; alkaline phosphatase, serum; aspartate
aminotransferase; bilirubin, total; bilirubin : creatinine ratio; calcium, serum; carbon dioxide,
total; chloride, serum; creatinine, serum; globulin, total; glucose, serum; potassium, serum;
protein, total, serum; sodium, serum); insulin; hemoglobin A1c; high sensitivity C-reactive
protein; homocysteine; lipid profile (triglycerides, total cholesterol, low-density lipoprotein,
high-density lipoprotein); nicotine and metabolite
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